Medicare Enrolled

Dr. Christopher Brown, MD

Gastroenterology · Stockbridge, GA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
150 N PARK TRL STE B, Stockbridge, GA 30281
7705070909
In practice since 2005 (20 years)
NPI: 1194715813 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Brown from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Brown? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Brown

Dr. Christopher Brown is a gastroenterology specialist in Stockbridge, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Brown performed 627 Medicare services across 590 unique beneficiaries.

Between the years covered by Open Payments, Dr. Brown received a total of $12,428 from 42 pharmaceutical and/or device companies across 727 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Brown is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 48% volume in GA $12,428 industry payments

Medicare Practice Summary

Medicare Utilization ↗
627
Medicare services
Top 48% in GA for gastroenterology
590
Unique beneficiaries
$109
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~31 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
146 $82 $314
Upper GI endoscopy with biopsy
A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities.
87 $83 $600
Colon polyp removal with endoscopic snare
This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination.
79 $209 $943
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
77 $114 $484
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
60 $62 $210
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
56 $102 $553
Colonoscopy for colorectal cancer screening
A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease.
29 $177 $747
Colonoscopy with biopsy
A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease.
24 $94 $793
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
23 $54 $317
Colonoscopy for colorectal cancer screening, high risk
A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease.
19 $180 $747
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
15 $66 $213
Colonoscopy
A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon.
12 $126 $747
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$12,428
Total received (2018-2024)
Avg $1,775/year across 7 years
Top 10% in GA for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
727
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,401 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$14 (0.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$13 (0.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,984
2023
$1,993
2022
$2,045
2021
$1,557
2020
$1,064
2019
$1,177
2018
$1,609

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$409
Janssen Biotech, Inc.
$302
Gilead Sciences, Inc.
$250
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$248
Phathom Pharmaceuticals, Inc.
$236
GENZYME CORPORATION
$228
Lilly USA, LLC
$137
IRONWOOD PHARMACEUTICALS, INC
$132
Ardelyx, Inc.
$129
Takeda Pharmaceuticals U.S.A., Inc.
$112
QOL Medical, LLC
$105
Merck Sharp & Dohme LLC
$96
Regeneron Healthcare Solutions, Inc.
$89
PFIZER INC.
$85
Celltrion USA Inc.
$74
Madrigal Pharmaceuticals
$65
Daiichi Sankyo Inc.
$62
Ipsen Biopharmaceuticals, Inc
$57
Organon Llc
$41
Celgene Corporation
$37
Medtronic, Inc.
$36
AIMMUNE THERAPEUTICS, INC.
$33
Intercept Pharmaceuticals, Inc.
$20
Top 3 companies account for 32.2% of 2024 payments
All-time payments by company (2018-2024) ›
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,975
AbbVie Inc.
$1,148
Gilead Sciences, Inc.
$1,100
ABBVIE INC.
$954
Janssen Biotech, Inc.
$841
Takeda Pharmaceuticals U.S.A., Inc.
$810
AbbVie, Inc.
$805
GENZYME CORPORATION
$429
Ironwood Pharmaceuticals, Inc
$369
PFIZER INC.
$367
Synergy Pharmaceuticals Inc
$363
Merck Sharp & Dohme LLC
$342
Merck Sharp & Dohme Corporation
$251
Intercept Pharmaceuticals, Inc.
$245
IRONWOOD PHARMACEUTICALS, INC
$244
Ardelyx, Inc.
$238
Phathom Pharmaceuticals, Inc.
$236
Daiichi Sankyo Inc.
$182
Celgene Corporation
$164
Nestle HealthCare Nutrition Inc.
$163
RedHill Biopharma Inc.
$142
Lilly USA, LLC
$137
Regeneron Healthcare Solutions, Inc.
$127
QOL Medical, LLC
$105
Celltrion USA Inc.
$74
INTERCEPT PHARMACEUTICALS, INC.
$73
Madrigal Pharmaceuticals
$65
Boston Scientific Corporation
$63
Ipsen Biopharmaceuticals, Inc
$57
Shire North American Group Inc
$56
Medtronic, Inc.
$54
NESTLE HEALTHCARE NUTRITION INC.
$50
Organon Llc
$41
AIMMUNE THERAPEUTICS, INC.
$33
Fresenius Kabi USA, LLC
$32
Ethicon US, LLC
$20
BOSTON SCIENTIFIC CORPORATION
$14
Alexion Pharmaceuticals, Inc.
$14
Concordia Pharmaceuticals Inc.
$14
Braintree Laboratories, Inc.
$13
Allergan Inc.
$13
Napo Pharmaceuticals Inc
$2
Top 3 companies account for 34.0% of all-time payments
Associated products mentioned in payments ›
Aemcolo · Amitiza · CREON · Creon · DIFICID · DUPIXENT · Donnatal · ENTYVIO · Entyvio · Epclusa · GATTEX · GENERAL ENDOCHOICE · HADLIMA · HUMIRA · Humira · IBSRELA · IDACIO · INFLECTRA · INJECTAFER · INTERSTIM · IQIRVO · Kanuma · LINZESS · Linzess · MAVYRET · MOTEGRITY · MOVIPREP · Mavyret · Mytesi · OCALIVA · OMVOH · RELISTOR · REMICADE · RENFLEXIS · RESMETIROM · RESOLUTION CLIP · RINVOQ · SIGNIA · SKYRIZI · SPYGLASS · STELARA · SUCRAID · SUTAB · TREMFYA · TRULANCE · Talicia · Trulance · UCERIS TABLETS · VEGZELMA · VIBERZI · VOQUEZNA · XELJANZ · XIFAXAN · ZENPEP · ZEPATIER · ZEPOSIA · ZYMFENTRA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for gastroenterology in GA.

Looking for a gastroenterology specialist in Stockbridge?
Compare gastroenterologists in the Stockbridge area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologists nearby

Geographic Context

Gastroenterologists within 10 mi
156
Per 100K population
63.6
County median income
$81,612
Nearest hospital
PIEDMONT HENRY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Brown is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 10% of GA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Brown experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Brown performed 146 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Brown receive payments from pharmaceutical companies?
Yes. Dr. Brown received a total of $12,428 from 42 companies across 727 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Brown's costs compare to other gastroenterologists in Stockbridge?
Dr. Brown's average Medicare payment per service is $109. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Brown) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →